Compounds > aromasil
Page last updated: 2024-08-24

aromasil and 9,10-dimethyl-1,2-benzanthracene

aromasil has been researched along with 9,10-dimethyl-1,2-benzanthracene in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19903 (50.00)18.7374
1990's2 (33.33)18.2507
2000's0 (0.00)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
di Salle, E; Giudici, D; Ornati, G; Panzeri, A; Zaccheo, T1
di Salle, E; Giudici, D; Lombardi, P; Zaccheo, T1
Di Salle, E; Zaccheo, T1
Briatico, G; di Salle, E; Giudici, D; Ornati, G; Zaccheo, T1
Di Salle, E; Giudici, D; Zaccheo, T1
Chekhun, VF; Grabovoy, AN; Lukyanova, NY; Svintsitsky, VS; Tarasova, TO; Tkalia, IG; Todor, IN; Vorobyova, LI1

Other Studies

6 other study(ies) available for aromasil and 9,10-dimethyl-1,2-benzanthracene

ArticleYear
Comparison of the effects of the irreversible aromatase inhibitor exemestane with atamestane and MDL 18962 in rats with DMBA-induced mammary tumours.
    European journal of cancer (Oxford, England : 1990), 1991, Volume: 27, Issue:9

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Androstadienes; Androstenedione; Animals; Antineoplastic Agents; Aromatase Inhibitors; Cell Division; Dose-Response Relationship, Drug; Endocrine Glands; Female; Luteinizing Hormone; Mammary Neoplasms, Experimental; Organ Size; Ovariectomy; Pargyline; Prolactin; Rats

1991
A new irreversible aromatase inhibitor, 6-methylenandrosta-1,4-diene-3,17-dione (FCE 24304): antitumor activity and endocrine effects in rats with DMBA-induced mammary tumors.
    Cancer chemotherapy and pharmacology, 1989, Volume: 23, Issue:1

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Androstadienes; Animals; Aromatase; Aromatase Inhibitors; Endocrine Glands; Female; Luteinizing Hormone; Mammary Neoplasms, Experimental; Organ Size; Ovary; Prolactin; Rats; Rats, Inbred Strains

1989
Effect of the irreversible aromatase inhibitor FCE 24304 on DMBA-induced mammary tumors in ovariectomized rats treated with testosterone.
    Cancer chemotherapy and pharmacology, 1989, Volume: 25, Issue:2

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Androstadienes; Animals; Antineoplastic Agents; Aromatase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Mammary Neoplasms, Experimental; Ovariectomy; Ovary; Rats; Rats, Inbred Strains; Testosterone

1989
Aromatase inhibition and experimental antitumor activity of FCE 24304, MDL 18962 and SH 489.
    Journal of steroid biochemistry, 1989, Volume: 34, Issue:1-6

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Androstadienes; Androstenedione; Animals; Antineoplastic Agents; Aromatase Inhibitors; Female; Humans; Luteinizing Hormone; Male; Mammary Neoplasms, Experimental; Microsomes; Orchiectomy; Ovary; Pargyline; Placenta; Pregnancy; Rats; Rats, Inbred Strains; Reference Values

1989
Inhibitory effect of combined treatment with the aromatase inhibitor exemestane and tamoxifen on DMBA-induced mammary tumors in rats.
    The Journal of steroid biochemistry and molecular biology, 1993, Volume: 44, Issue:4-6

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Adrenal Glands; Androstadienes; Animals; Antineoplastic Agents; Aromatase Inhibitors; Drug Synergism; Female; Mammary Neoplasms, Experimental; Organ Size; Ovary; Pituitary Gland; Rats; Rats, Sprague-Dawley; Tamoxifen; Uterus

1993
Increase of antitumor activity of cisplatin using agonist of gonadotropin-realising hormone and inhibitor of aromatase on the model of ascites ovarian tumor.
    Experimental oncology, 2014, Volume: 36, Issue:3

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Androstadienes; Animals; Antineoplastic Agents; Apoptosis; Aromatase Inhibitors; Ascites; Cell Proliferation; Cisplatin; Disease Models, Animal; Drug Synergism; Female; Gonadotropin-Releasing Hormone; Immunoenzyme Techniques; Ovarian Neoplasms; Rats; Rats, Wistar; Triptorelin Pamoate; Tumor Cells, Cultured

2014